Physician profile
Charity E Mitchell
NPI 1073992293
$2,209.47
in general payments reported to CMS, 2019-2025
28 companies · $468 in 2025
The $468 reported for 2025 was more than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $49.54 · 2022: $470 · 2023: $430 · 2024: $792 · 2025: $468.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,690.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,690.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $321.49 | 2024 | 2nd Gen Centrimag Primary Console |
| Astrazeneca Pharmaceuticals LP | $252.71 | 2021-2025 | Tezspire, Fasenra, Airsupra |
| Glaxosmithkline, LLC. | $172.62 | 2022-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Regeneron Healthcare Solutions, INC. | $160.92 | 2022-2025 | Dupixent |
| Janssen Pharmaceuticals, INC | $141.45 | 2021-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $120.56 | 2022-2025 | Ofev |
| Genzyme Corporation | $110.18 | 2022-2024 | |
| Amgen INC. | $109.55 | 2022-2025 | Tezspire |
| Grifols USA, LLC | $93.73 | 2021-2025 | Prolastin-C Liquid |
| Abbvie INC. | $93.15 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $78.91 | 2022-2025 | Glassia |
| Abiomed | $65.70 | 2022-2025 | |
| Viatris Specialty LLC | $62.38 | 2025 | Yupelri |
| Pfizer INC. | $51.41 | 2022-2025 | |
| United Therapeutics Corporation | $50.39 | 2024-2025 | Tyvaso, Tyvaso |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inogen, INC. | $47.37 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Mylan Specialty L.P. | $45.06 | 2023 | Yupelri |
| Actelion Pharmaceuticals US, INC. | $33.90 | 2023 | Opsumit, Uptravi |
| Novartis Pharmaceuticals Corporation | $31.04 | 2023-2024 | |
| Mallinckrodt Hospital Products INC. | $26.08 | 2024 | Acthar |
| Gilead Sciences, INC. | $24.49 | 2024 | |
| Merck Sharp & Dohme LLC | $18.73 | 2022 | |
| Atricure, INC. | $18.70 | 2024 | |
| Electromed, INC. | $18.65 | 2022 | |
| Baxter Healthcare | $17.01 | 2022 | |
| Philips North America LLC | $16.29 | 2025 | Vest Therapy Und |
| Covis Pharma Gmbh | $15.09 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $11.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charity Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.